DK1763673T3 - Anvendelser af gelformuleringer - Google Patents

Anvendelser af gelformuleringer

Info

Publication number
DK1763673T3
DK1763673T3 DK05757674.6T DK05757674T DK1763673T3 DK 1763673 T3 DK1763673 T3 DK 1763673T3 DK 05757674 T DK05757674 T DK 05757674T DK 1763673 T3 DK1763673 T3 DK 1763673T3
Authority
DK
Denmark
Prior art keywords
applications
gel formulations
formulations
gel
Prior art date
Application number
DK05757674.6T
Other languages
English (en)
Inventor
Paul Smith
Laurence Patterson
Rachel Jane Errington
Original Assignee
Biostatus Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biostatus Ltd filed Critical Biostatus Ltd
Application granted granted Critical
Publication of DK1763673T3 publication Critical patent/DK1763673T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/145—Hydrogels or hydrocolloids
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16—Organic compounds
    • C11D3/37—Polymers
    • C11D3/3703—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • C11D3/3707—Polyethers, e.g. polyalkyleneoxides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
    • G01N21/27—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands using photo-electric detection ; circuits for computing concentration
    • G01N21/274—Calibration, base line adjustment, drift correction
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
    • G01N21/27—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands using photo-electric detection ; circuits for computing concentration
    • G01N21/274—Calibration, base line adjustment, drift correction
    • G01N21/278—Constitution of standards
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • G01N21/645—Specially adapted constructive features of fluorimeters
    • G01N21/6456—Spatial resolved fluorescence measurements; Imaging
    • G01N21/6458—Fluorescence microscopy
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
    • G01N33/545—Synthetic resin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Mathematical Physics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
DK05757674.6T 2004-07-02 2005-07-01 Anvendelser af gelformuleringer DK1763673T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0414825.0A GB0414825D0 (en) 2004-07-02 2004-07-02 Gel formulations and uses thereof
PCT/GB2005/002603 WO2006003423A2 (en) 2004-07-02 2005-07-01 Gel formulations and uses thereof

Publications (1)

Publication Number Publication Date
DK1763673T3 true DK1763673T3 (da) 2014-07-28

Family

ID=32843440

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05757674.6T DK1763673T3 (da) 2004-07-02 2005-07-01 Anvendelser af gelformuleringer

Country Status (9)

Country Link
US (2) US7723085B2 (da)
EP (1) EP1763673B1 (da)
JP (1) JP2008504045A (da)
AU (1) AU2005258935B2 (da)
CA (1) CA2571695A1 (da)
DK (1) DK1763673T3 (da)
ES (1) ES2488847T3 (da)
GB (1) GB0414825D0 (da)
WO (1) WO2006003423A2 (da)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0414825D0 (en) 2004-07-02 2004-08-04 Biostatus Ltd Gel formulations and uses thereof
RU2394915C2 (ru) * 2006-03-24 2010-07-20 Александр Борисович Четверин Бесконтактные способы обнаружения молекулярных колоний, наборы реагентов и устройство для их осуществления
DE102007048409A1 (de) * 2007-10-09 2009-04-16 Carl Zeiss Microimaging Gmbh Verfahren zum Positionieren von biologischen Proben in einer mikroskopischen Anordnung
GB0721564D0 (en) * 2007-11-02 2007-12-12 Ge Healthcare Uk Ltd Microscopy imaging phantoms
CA2744100C (en) 2008-10-21 2020-06-30 The General Hospital Corporation Cell transplantation
EP2452192A1 (en) * 2009-07-08 2012-05-16 Zf Screens B.V. High throughput method and system for in vivo screening
WO2011116072A1 (en) 2010-03-16 2011-09-22 Escape Therapeutics, Inc. Hybrid hydrogel scaffold compositions and methods of use
KR101809301B1 (ko) 2010-08-06 2018-01-18 더 제너럴 하스피털 코포레이션 두잉 비즈니스 애즈 매사츄세츠 제너럴 하스피털 세포 처리 시스템 및 장치
AU2013300171B2 (en) * 2012-08-09 2017-09-14 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for preparing biological specimens for microscopic analysis
US9125841B2 (en) * 2013-02-26 2015-09-08 Johnson & Johnson Consumer Inc. Oral care compositions
US20160256714A1 (en) * 2013-10-01 2016-09-08 Empire Technology Development Llc Visualization of beam trajectories in radiation therapy
EP3114483A1 (en) 2014-03-03 2017-01-11 Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. Method and device for detection of pseudomonas aeruginosa
KR20170013855A (ko) 2014-05-30 2017-02-07 더 보드 오브 트러스티스 오브 더 리랜드 스탠포드 쥬니어 유니버시티 큰 손상되지 않은 조직 샘플들을 이미징하기 위한 방법들 및 디바이스들
JP6500897B2 (ja) * 2014-06-20 2019-04-17 コニカミノルタ株式会社 表面プラズモン共鳴励起増強蛍光分光(spfs)用センサーチップ、spfs測定法、およびspfs用キット
CN104075922A (zh) * 2014-07-04 2014-10-01 中国水产科学研究院淡水渔业研究中心 一种制备扫描电镜用寄生虫样品的环氧树脂包埋方法
CN107075545A (zh) 2014-07-30 2017-08-18 哈佛学院院长及董事 探针文库构建
KR101687291B1 (ko) * 2014-09-19 2016-12-19 (주)세포바이오 3차원 세포배양 시스템 및 이를 이용한 세포 배양 방법
JP6692834B2 (ja) * 2015-02-09 2020-05-13 スリングショット バイオサイエンシーズ, インコーポレイテッド 調整可能な光学特性を有するヒドロゲル粒子およびその使用の方法
US10371610B2 (en) 2016-02-23 2019-08-06 Noul Co., Ltd. Contact-type patch, staining method using the same, and manufacturing method thereof
KR102478639B1 (ko) 2016-02-23 2022-12-19 노을 주식회사 표지 물질을 저장하는 패치, 이를 이용하는 조직 진단 방법 및 장치
KR20170099738A (ko) 2016-02-23 2017-09-01 노을 주식회사 접촉식 염색 패치 및 그 제조 방법
JP7173867B2 (ja) 2016-04-22 2022-11-16 ベクトン・ディキンソン・アンド・カンパニー 多重高分子色素デバイス及びその使用方法
US11389470B2 (en) * 2016-07-12 2022-07-19 Centre National De La Recherche Scientifique Compositions useful for mucosal healing
US11320437B2 (en) 2017-02-08 2022-05-03 Becton, Dickinson And Company Dried dye reagent devices and methods for making and using the same
WO2018218150A1 (en) 2017-05-26 2018-11-29 President And Fellows Of Harvard College Systems and methods for high-throughput image-based screening
US11035740B1 (en) * 2017-07-31 2021-06-15 Prasidiux, Llc Stimulus indicating device employing thermoreversible amphiphilic gels
AU2019257320B2 (en) * 2018-04-20 2022-04-07 Illumina, Inc. Methods of encapsulating single cells, the encapsulated cells and uses thereof
JP7551507B2 (ja) 2018-06-01 2024-09-17 イテリオン・セラピューティクス・インコーポレイテッド テガビビントおよび関連化合物の製剤
CA3113271A1 (en) 2018-10-26 2020-04-30 Illumina, Inc. Modulating polymer beads for dna processing
CN113396006A (zh) 2018-11-13 2021-09-14 贝克顿·迪金森公司 干燥试剂滤网及其制造和使用方法
CA3122569A1 (en) 2018-12-13 2020-06-18 President And Fellows Of Harvard College Amplification methods and systems for merfish and other applications
WO2020243564A1 (en) * 2019-05-30 2020-12-03 Beckman Coulter, Inc. Methods and systems for immobilizing a biological specimen for microscopic imaging
TW202141019A (zh) 2020-01-24 2021-11-01 美商史林夏特生化公司 類細胞校正粒子之組合物與方法
CN115485556B (zh) 2020-05-04 2026-02-03 弹弓生物科学公司 用于多路复用测定的被动光学条形码化的组合物和方法
EP4259093B1 (en) 2020-12-11 2025-08-13 UroGen Pharma Ltd. Material and method for treating cancer
CN113244973B (zh) * 2021-07-15 2021-10-08 成都博奥晶芯生物科技有限公司 凝胶基质点样液及空白点样液、三维凝胶芯片及制备方法
EP4423250A1 (en) 2021-10-29 2024-09-04 Slingshot Biosciences, Inc. Hydrogel particles as feeder cells and as synthetic antigen presenting cells
WO2023215886A1 (en) 2022-05-05 2023-11-09 Slingshot Biosciences, Inc. Engineered particles as red blood cell mimics and compositions containing same for hematology
WO2023235885A1 (en) 2022-06-02 2023-12-07 Slingshot Biosciences, Inc. Apoptotic cell mimic
CN120712108A (zh) 2022-10-26 2025-09-26 弹弓生物科学公司 具有可调整光学性质的大小可调整合成颗粒和用于使用其进行免疫细胞激活的方法
CN121986254A (zh) 2023-08-29 2026-05-05 弹弓生物科学公司 Cd34干细胞模拟物

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4689307A (en) * 1986-09-02 1987-08-25 Caribbean Microparticles Corporation Fluorescence microscopy sample mounting method and structure
US5137609A (en) * 1992-01-31 1992-08-11 Biometric Imaging Inc. Differential separation assay
JP3414444B2 (ja) * 1993-06-08 2003-06-09 倭 窪田 固定化用器具、これを用いた生物組織の固定化法および培養法
US5628981A (en) * 1994-12-30 1997-05-13 Nano Systems L.L.C. Formulations of oral gastrointestinal diagnostic x-ray contrast agents and oral gastrointestinal therapeutic agents
US5804420A (en) * 1997-04-18 1998-09-08 Bayer Corporation Preparation of recombinant Factor VIII in a protein free medium
US6171780B1 (en) * 1997-06-02 2001-01-09 Aurora Biosciences Corporation Low fluorescence assay platforms and related methods for drug discovery
US7560275B2 (en) * 1999-12-30 2009-07-14 Vbi Technologies, L.L.C. Compositions and methods for generating skin
US20030104347A1 (en) * 2000-03-21 2003-06-05 Yuichi Mori Coating material for living organism tissue, coated product from living organism tissue and method of coating living organism material
US9709559B2 (en) * 2000-06-21 2017-07-18 Bioarray Solutions, Ltd. Multianalyte molecular analysis using application-specific random particle arrays
US6905881B2 (en) * 2000-11-30 2005-06-14 Paul Sammak Microbead-based test plates and test methods for fluorescence imaging systems
EP1456371A1 (en) * 2001-12-05 2004-09-15 Dow Global Technologies Inc. Method for immobilizing a biologic in a polyurethane-hydrogel composition, a composition prepared from the method, and biomedical applications
EP1474772A4 (en) * 2002-02-14 2005-11-09 Immunivest Corp METHODS AND ALGORITHMS FOR COUNTING CELLS IN A SMALL CYTOMETER
CA2482856A1 (en) * 2002-04-15 2003-10-30 American National Red Cross Plasma protein-binding ligands
US7452565B2 (en) * 2003-06-12 2008-11-18 Sukanta Banerjee Immobilization of bead-displayed ligands on substrate surfaces
GB0414825D0 (en) 2004-07-02 2004-08-04 Biostatus Ltd Gel formulations and uses thereof

Also Published As

Publication number Publication date
ES2488847T3 (es) 2014-08-29
US9759715B2 (en) 2017-09-12
US20080182287A1 (en) 2008-07-31
US7723085B2 (en) 2010-05-25
WO2006003423A2 (en) 2006-01-12
WO2006003423A3 (en) 2006-04-27
US20120219470A1 (en) 2012-08-30
GB0414825D0 (en) 2004-08-04
CA2571695A1 (en) 2006-01-12
AU2005258935B2 (en) 2011-09-08
JP2008504045A (ja) 2008-02-14
EP1763673B1 (en) 2014-05-07
EP1763673A2 (en) 2007-03-21
AU2005258935A1 (en) 2006-01-12

Similar Documents

Publication Publication Date Title
DK3395339T3 (da) Hurtigt opløsende formulering af cinacalcet-hcl
DK1962886T3 (da) Stabile proteinformuleringer
DK1802579T3 (da) Derivater af 3-arylaminopyridin
PT1788725E (pt) Comunicações sincronizadas de difusão/grupos de entidades
DK1778618T3 (da) Syntese af triethylentetraminer
DE602005012267D1 (de) N von geräten
DK1653807T3 (da) Anvendelse af dermale mikroorganer
DK1751843T3 (da) Forbelastning af elektroaktive polymer
DK1992697T3 (da) Fremstilling af TNFR-Fc
DE602004008136D1 (de) Härtbare Zusammensetzung
EP1653935A4 (en) INFLAMMATORY FORMULATIONS
DK1587542T3 (da) Anvendelse af anti-CD100-antistoffer
DK1931315T3 (da) Depotformuleringer af nalbufin
DE502005005035D1 (de) Wischblatt
DK1879844T3 (da) Fremstilling af natriumdiformiat
DE602005008726D1 (de) Verwendet
IS8309A (is) Lyfjablöndur
DK1516540T3 (da) Anvendelse af vitamin D-forbindelser
CR9144A (es) Formulaciones de benzoxazoles sustituidos
DK2097068T3 (da) Formuleringer af peg-interferon-alpha-konjugater
EP1692279A4 (en) VIRUS PREPARATIONS CONTAINING A CONSERVATIVE
NO20043305D0 (no) Preparation of lodixanol
DK1827483T3 (da) Terapeutiske formuleringer af keratinocyt-vækstfaktor
DK1814977T3 (da) Arthrospira-baserede sammensætninger og anvendelser deraf
PT1763520E (pt) Utilização de benzopiranonas trissubstituídas